Fluorescent labelling and biodistribution of latex nanoparticles formed by surfactant-free RAFT emulsion polymerisation by Poon, C. K. et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Poon, C. K., Tang, O., Chen, X.-C., Kim, B., Hartlieb, Matthias, Pollock, C. A., Hawkett, B. S. 
and Perrier, Sébastien. (2016) Fluorescent labelling and biodistribution of latex nanoparticles 
formed by surfactant-free RAFT emulsion polymerisation. Macromolecular Bioscience. 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/84348   
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  Copyright © 
and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable the 
material made available in WRAP has been checked for eligibility before being made 
available. 
 
Copies of full items can be used for personal research or study, educational, or not-for profit 
purposes without prior permission or charge.  Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
"This is the peer reviewed version of the following article Poon, C. K., Tang, O., Chen, X.-C., 
Kim, B., Hartlieb, Matthias, Pollock, C. A., Hawkett, B. S. and Perrier, Sébastien. (2016) 
Fluorescent labelling and biodistribution of latex nanoparticles formed by surfactant-free 
RAFT emulsion polymerisation. Macromolecular Bioscience. which has been published in 
final form at http://doi.org/10.1002/mabi.201600366 This article may be used for non-
commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving." 
 
A note on versions: 
The version presented here may differ from the published version or, version of record, if 
you wish to cite this item you are advised to consult the publisher’s version.  Please see the 
‘permanent WRAP URL’ above for details on accessing the published version and note that 
access may require a subscription. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
1 
 
Fluorescent labelling and biodistribution of latex nanoparticles formed by 
surfactant-free RAFT emulsion polymerisation  
 
Cheuk Ka Poon1, Owen Tang2, Xin-Ming Chen2, Byung Kim1, Matthias Hartlieb,3 Carol A. 
Pollock2, Brian S. Hawkett*1, Sébastien Perrier*1,3 
1 Key Centre for Polymers & Colloids, School of Chemistry, Building F11, The University of 
Sydney, NSW 2006, Australia 
2 Kolling Institute of Medical Research, Royal North Shore Hospital and The University of 
Sydney, St Leonards, NSW 2065, Australia 
3 Department of Chemistry, The University of Warwick, Coventry, CV4 7AL, UK 
Brian.hawkett@sydney.edu.au; s.perrier@warwick.ac.uk 
 
TOC 
 
The synthesis and labelling of acrylamide stabilized latex nanoparticles is shown. Particle 
preparation was performed using surfactant-free RAFT emulsion polymerisation. Labelling 
was achieved covalently by amidation with rhodamine B amine. Particle tracing was enabled 
by labelling the sterically stabilised latex particles chemically with rhodamine B. The 
biodistribution was investigated in vitro and in vivo. 
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Abstract 
We report the preparation of a novel range of functional polyacrylamide stabilised 
polystyrene nanoparticles, obtained by surfactant-free reversible addition-fragmentation chain 
transfer (RAFT) emulsion polymerisation, their fluorescent tagging, cellular uptake and 
biodistribution. We show the versatility of the RAFT emulsion process for the design of 
functional nanoparticles of well-defined size that can be used as drug delivery vectors. 
Functionalisation with a fluorescent tag offers a useful visualisation tool for tracing, 
localisation and clearance studies of these carriers in biological models. The studies were 
carried out by labelling the sterically stabilised latex particles chemically with rhodamine B. 
The fluorescent particles were incubated in a healthy human renal proximal tubular cell line 
model, and intravenously injected into a mouse model. Cellular localisation and 
biodistribution of these particles on the biological models were explored.  
 
Introduction 
Polymeric nanoparticles are of paramount importance in the field of nanomedicine. 
Nanoparticles are able to protect their payload from degradation or undesired interaction,1 
solubilize drugs to enable administration or increase the possible dosage,2 or induce 
selectivity by passive (e.g. enhanced permeability and retention (EPR) effect)3 or active (e.g. 
by attachment of antibodies,4 sugars5 or peptides)6 targeting. Such systems can be synthesized 
by a large number of different methods starting either from a polymeric precursor (e.g. 
nanoprecipitation, solvent switch) or directly from monomers (emulsion polymerisation 
methods).7 Surfactant-free reversible addition−fragmentation chain transfer (RAFT) emulsion 
polymerisation displays a particularly valuable method in a biomedical context, as no 
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surfactants are required to stabilize the formed nanoparticles.8-10 Hence no molecules can 
desorb from the particle surface and cause unwanted side-effects or destabilize the colloidal 
particles.11 The synthesis is utilized via the use of chain transfer agent (CTA)-end-capped 
diblock copolymers in emulsion.12-16 The diblock is dispersed in a micellar manner and chain 
extended with a hydrophobic monomer to form nanoparticles. The potential of these systems 
in a biomedical context was already demonstrated by Stenzel et al. for the production of 
bacteria interactive particle systems,17 or by Wang et al. with redox responsive particels.18 We 
have previously demonstrated the successful conjugation of microRNA (miRNA) duplex to 
sterically stabilised latex particles formed by surfactant-free RAFT emulsion 
polymerisation.19 Fluorescence imaging is a popular non-invasive visualisation technique for 
biological tracing, diagnosis, detection/sensing and localisation studies in vitro, in vivo and ex 
vivo.20-23 Owing to their high sensitivity, versatility and the increasing need to develop next-
generation nanomedicines, fluorescent labels are widely incorporated into drug delivery 
vectors for monitoring the cellular uptake,24 biodistribution25 and clearance26 of the carriers in 
biological models. 
Iron oxide, silica and polymeric particles are common examples of carriers that can be 
visualised in biological environments with the appropriate fluorescent labelling. For instance, 
Rosseinsky et al. demonstrated the targeting of epithelial cell adhesion molecule (EPCAM) 
receptor on a human pancreatic cancer cell line with rhodamine-labelled EPCAM-iron oxide 
nanoparticle conjugates.27 Zhang et al. studied the in vivo biodistribution and excretion route 
of surface-modified silica nanoparticles doped with tris(2,2-bipyridyl) dichlororuthenium (II) 
hexahydrate (RuBPY) in mice.28 Likewise, poly(ethylene glycol)-terminated silica 
nanoparticles tagged with RuBPY dye have been demonstrated to transport across the blood 
brain barrier in vitro and in vivo by the group of Yang.29 Polystyrene beads loaded with 
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oxygen-sensitive platinum(II) meso-tetrakis-(pentaﬂuorophenyl)-porphyrinato-complex dye 
were used for intracellular oxygen content sensing in epithelial normal rat kidney cell line.30  
Rhodamine labels possess a number of attractive physical properties for biological imaging 
because of their high water-solubility, large extinction coefficient in aqueous solution, high 
quantum yield, tolerance to photobleaching, relatively long fluorescence lifetime,31 as well as  
emission in the visible light region.32 
Herein, we demonstrate the synthesis of latex nanoparticles by surfactant free RAFT emulsion 
polymerisation. Particles were synthesized in two different sizes (11 and 22 nm) by variation 
of the monomer to macro-CTA ratio. Free carboxylic acid functions on the particle surface 
were used to attach rhodamine as a fluorescent label in order to examine the cellular uptake 
and in vivo bio-distribution (Scheme 1). In vitro cellular uptake was investigated using the 
human renal proximal tubular cell line (HK2) model for uptake and localisation studies 
through fluorescent live-cell imaging. HK2 cells were used as models in light of our previous 
study on miRNA delivery to HK2 cells by nanoparticles, as a mean to decrease the production 
of fibronectin, which plays a key role in the development of renal fibrosis.19  Using in vivo 
fluorescent imaging, bio-distribution of 22 nm labelled particles was probed using a mouse 
model and the accumulation of these fluorescent particles in mouse organs was then examined 
via ex vivo imaging.  
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Scheme 1. Conjugation of rhodamine B-amine to PS latex particles. 
Results and discussion 
Synthesis of poly(acrylamide) stabilized latex nanoparticles 
The synthesis of poly(acrylamide) (PAAm) stabilized poly(styrene) (PS) nanoparticles was 
carried out by surfactant free RAFT emulsion polymerisation using a macro-CTA. This 
amphiphilic diblock copolymer consisting of PAAm as a water soluble block and PS as 
selective block was produced by RAFT polymerisation. Acrylamide (AAm) was polymerized 
in a water-dioxane solvent mixture (60/40 v/v) using 2-propanoyl butyl trithiocarbonate 
(PABTC) as chain transfer agent. The carboxylic acid located on the R groups of the CTA 
was necessary for stabilization of latex particles, as well as for later attachment of the dye. 
Conversion (93%) and degree of polymerisation (DP = 14) were determined by 1H-NMR 
spectroscopy comparing signals of the polymer backbone with vinyl peaks of the monomer or 
the methyl peak of the CTA Z-group, respectively (Figure S1). ESI mass spectrometry shows 
a main distribution of the desired PAAm homopolymer bearing R group and trithiocarbonate 
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Z-group of the RAFT agent (Figure S2). A small doubly charged distribution could be 
attributed to the termination product as a result of the combination of two growing chains. 
Block extension was attempted without purification by addition of styrene in a dioxane/water 
mixture, thus altering the solvent ration to (70/30 v/v). After polymerisation monomer 
conversion was found to be 90 % resulting in a DP of 8 for the PS block (Figure S3). Due to 
poor solubility of the RAFT agent ESI-MS as well as size exclusion chromatography could 
not be performed.  
In order to utilize the produced macro-CTA for RAFT emulsion polymerisation, micellisation 
was induced by a change in the solvent ratio of the polymerisation mixture. The non-purified 
polymerisation solution of PAAm14-b-PS8 was, therefore, diluted with water in the presence 
of NaOH. The base was required to deprotonate the carboxylic acid on the R-group of the 
polymer leading to an enhanced stabilization of the micelles by the anionic charges on the 
corona. It should be noted, that the trithiocarbonate, which might be hydrolysed under 
alkaline conditions is located at the PS chain end within the core compartment of the micelle, 
leading to a protection of the CTA. A diameter of 9.3 nm with a PDI of 0.216 was measured 
using Dynamic light scattering (DLS).  
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Figure 1. PS latex particles size distributions measured from (a) DLS intensity and (b) HDC.  
 
In order to form nanoparticles, styrene was added to the solution of macro CTA micelles and 
dispersed by stirring. After the mixture became homogeneous, radical initiator, as well as a 
further portion NaOH, to ensure colloidal stability, was added. The polymerisation was 
performed at elevated temperature until the reaction solution became clear. This observation 
indicates a consumption of styrene from the dispersion and the formation of PAAm stabilized 
nanoparticles. Using different monomer to macro-CTA ratios (8:1 and 150:1, respectively) the 
final size of the nanoparticles was varied. In the case of 8:1 monomer CTA ratio, 99% of 
monomer conversion was achieved and resulting particles were studied by DLS (d = 11 nm, 
PDI = 0.159) and hydrodynamic chromatography (HDC) (d = 13 nm) (Figure 1, Table 1). 
Increased styrene content lead to the formation of particles with a diameter of 22 nm (DLS) 
and 25 nm (HDC), respectively at a monomer conversion of 72%. Both nanoparticle solutions 
were purified by dialysis and investigated by transmission electron microscopy (TEM) 
resulting in similar size values to those obtained by scattering and chromatography (Figure 2). 
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The slightly decreased diameter detected by TEM can be explained by the collapse of the 
stabilizing polyacrylamide chains onto the particle surface when the particles were dried 
down on the TEM grid.  
Table 1: Characterization data of polymeric precursors and polymers constituting latex 
nanoparticles. 
Sample 
NMR DLS HDC TEM 
Labelling efficiency 
(%) DP 
(AAm) 
DP 
(S) Mn Conversion 
Size 
(d, nm) PDI 
Size 
(d, nm) CV 
Size 
(d, nm) 
P(AAm) 14 - 1,200 93 - - - - - - 
Macro-CTA 14 8 2,100 90 9.3 0.216 - - - - 
NP 11 nm 14 16 2,900 99 11 0.159 13 10 7.5 10 
NP 22 nm 14 116 13,300 72 22 0.167 25 9 17 12 
 
 
Figure 2. TEM images of PS latex particles synthesised from RAFT emulsion polymerisation 
after dialysis. Styrene monomer fed relative to macro-RAFT: (a) 8 equivalents, (b) 150 
equivalents. 
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Fluorescence labelling of latex nanoparticles 
The synthesis of the rhodamine-PS latex particle conjugate was carried out in two steps: 1) 
The preparation of rhodamine B amine by the hydrolysis of rhodamine isothiocyanate; 2) The 
conjugation of rhodamine B amine to the carboxylic acids on the ends of the stabilizer chains 
via EDC/NHS coupling.  
In order to synthesize an amine functional rhodamine derivative, commercially available 
rhodamine B isothiocyanate (RBITC) was hydrolysed in an aqueous environment. The dye 
was hydrolysed in water over night and the reaction was monitored by ESI mass spectrometry 
(Figure 3). Addition of water resulted in the formation of a thiocarbamate, which reacted into 
the amine by elimination of cabonylsulfide (Scheme S1).33,34 Absence of a peak at m/z 500 
indicated the complete hydrolysis of the isothiocyanate. The presence of the dimeric 
derivative is a result of the reaction of isothiocyanate moieties with already hydrolysed dye. 
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Figure 3. ESI-MS of RBITC (a) before and (b) after hydrolysis reaction. Signals at 458 m/z, 
500 m/z correspond to the amine and isothiocyanate derivatives of rhodamine B, respectively. 
Signal at 958 m/z represents thiourea-linked rhodamine dimer.  
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Rhodamine B amine was, subsequently, used for labelling the PS latex particles. Aiming to 
functionalize 10% of functional groups on the ends of the stabilizer chains with the 
fluorescent dyes, carboxylic acid groups were first activated by 12 equivalents EDC and 
25 equivalents NHS per carboxylic acid for 60 minutes. As the shell of the particles is densely 
populated with carboxyl groups and, therefore, highly charged a large excess of activation 
reagents was used to ensure (partial) activation. Subsequently, the reaction mixture was added 
to the aqueous rhodamine B amine solution. A 30% excess of the rhodamine dye was supplied 
for the reaction to compensate for the presence of thiourea-linked rhodamine dimer resulted 
from RBITC hydrolysis. After purification by dialysis, the rhodamine-tagged particles were 
characterised by UV-Vis and fluorescence spectroscopy. The characteristics absorption peak 
at 310 nm in Figure 4Figure 4 corresponds to the trithiocarbonate group of the CTA of PS 
latex particles.35  
Absorbance of the rhodamine B of labelled nanoparticles was observed at 562 nm. The signal 
shows a red shift of 10 nm as compared to the free dye (Figure 4). The particles exhibit a 
maximum fluorescence excitation and emission wavelengths at 562 nm and 583 nm, 
respectively (Figure 5). The observed wavelengths also exhibited a bathochromic shift of 
11 nm from the maximum excitation and emission of the free dye. The shifts of absorption 
and fluorescence spectra were attributed to a change in the fluorophore chemical structure and 
chemical environment surrounding the fluorophore, which were strong evidence for 
attachment of dye molecules to the particles.36-38 The amount of rhodamine dye loaded onto 
the PS latex particles was determined using the Beer-Lambert law with the pre-determined 
extinction coefficient (ε) of the free dye in water (ε = 40400 M-1·cm-1 at 552 nm, (Figure S4) 
and known particle concentration. The conjugation efficiencies for the 11 nm and 22 nm 
particles were found to be 10% and 12%, respectively in regard to the total amount of 
carboxyl groups on the particle surface (see Supporting Information for calculation). These 
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are equivalent to attaching 10 and 14 rhodamine molecules to the 11 nm and 22 nm particles 
correspondingly.  
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Figure 4. Example UV-Vis absorption spectra of rhodamine B amine (RB-NH2) and 
rhodamine-tagged particles (RB-labelled NP) in water.  
 
 
Figure 5. Example fluorescence (a) excitation and (b) emission spectra of free rhodamine B 
amine (RB-NH2) and rhodamine-tagged PS latex particles (RB-labelled NP).  
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Cellular uptake of rhodamine-tagged PS latex particles. Human renal proximal tubular cells 
(HK2) were chosen as the model cell line for studying the nanoparticle uptake in vitro. The 
cellular uptake of the rhodamine-labelled particles was observed by confocal microscopy. 
HK2 cells were incubated with the fluorescent particles for 24 hours before imaging. The 
nuclei of the cells were stained with blue fluorescent 4',6-diamidino-2-phenylindole (DAPI) 
and Hoechst dyes for visualising the uptake of 11 nm and 22 nm particles, respectively. HK2 
cells without dosing with rhodamine-tagged particles were used as the negative control for the 
studies. Confocal images of HK2 cells dosed with 11 nm and 22 nm rhodamine-tagged 
particles are shown in Figure  and Figure  correspondingly. Cellular uptake of particles is 
evident from the red fluorescence within the boundaries of the cellular membrane as shown 
by comparison of reflexion image and the red fluorescence channel in the merged pictures. 
The particles were found inside the vesicular structures of the cells, implying that they were 
internalised and taken up by the cells during the 24 hour incubation. The punctuate structure 
of the red fluorescence signals in the rhodamine channel indicates a lysosomal or endosomal 
colocalization. As nanoparticle system in this size range is predominantly uptaken via 
endocytosis, this would be in agreement with their localization.39,40 The intracellular and 
presumable cytoplasmic localisation suggest the particles can be used for the intracellular 
delivery of mature miRNA, which can only be processed into RNA-induced silencing 
complexes (RISC) in the cytoplasm for targeting the corresponding messenger RNA 
(mRNA).41 For such application, the nanoparticles would only be required to cross the cellular 
membrane to reach the target site, without the need to cross the nuclei barrier. The reversible 
covalent decoration of such particles using miRNA was previously described by our group.19 
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Figure 6. Confocal images of HK2 cells dosed with 22 nm rhodamine-tagged PS latex 
particles (red fluorescence). The cell nuclei were stained with DAPI (blue fluorescence). 
Scale bar = 25 µm.   
 
Figure 7. Confocal images of HK2 cells dosed with 11 nm rhodamine-tagged PS latex 
particles (red fluorescence). The cell nuclei were stained with Hoechst (blue fluorescence). 
Scale bar = 25 µm. 
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In vivo and ex vivo biodistribution of rhodamine-labelled PS latex particles.  
The biodistribution of rhodamine-tagged PS latex particles was studied in healthy mice as 
biological models. The 22 nm particles were selected for the investigation. Following 
intravenous administration of the 22 nm rhodamine-labelled particles, the mouse model was 
exposed for fluorescence imaging for the detection of rhodamine signals in vivo. Figure c 
reveals that red fluorescence was emitted from the vasculature of the mouse torso and limbs, 
suggesting the rhodamine-tagged particles have been administered into the bloodstream and 
were transported through the cardiovascular system. The mouse was anatomised for ex vivo 
studies 40 minutes after dosing with the fluorescent particles. The heart, lungs, liver and 
kidneys were dissected from the mouse and their fluorescence images were collected. All the 
dissected organs emitted rhodamine fluorescence signals (Set II in Figure b and Figure c) as 
opposed to the organs obtained from the negative control mouse (without particle injection, 
Set I in Figure b and Figure c). The fluorescence indicated that the rhodamine-tagged particles 
had been distributed to the major organs through blood circulation. Accumulation of the 
fluorescent particles appeared to be highest in the liver, which showed the strongest 
fluorescence intensity. The lungs also exhibited a prominent uptake of the fluorescent 
particles, followed by the kidneys and the heart. Since more than 50% of the cardiac blood 
output is received by the lung vasculature, depositions of particles there was anticipated as the 
particles were transported through the mouse bloodstream via intravenous administration.42 
The high accumulation of particles in the lungs could be explained by the extensive capillary 
network covering the pulmonary alveoli, which contain fine structures of capillaries with 
diameter ranging between 1 µm and 5 µm. The particles were expected to be transported 
slower in these capillaries than in other blood vessels, thereby being retained in the organ.42 
The heavy deposition of particles in the liver might indicate their possible elimination by the 
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liver Kupffer cells through the reticuloendothelial system (RES), which could be associated 
with systemic administration of the nanoparticles.43-45  
 
 
(a) (b) (c) 
Figure 8. In vivo images of the mouse model after intravenous injection of 22 nm rhodamine-
labelled PS latex particles. Biodistribution of the particles (red fluorescence) was studied by 
imaging the mouse model with (a) X-ray (b) fluorescence and (c) X-ray/fluorescence overlay 
modes. An eppendorf tube containing the 22 nm rhodamine-tagged latex particles before 
injection was placed next to the mouse model for comparing with the fluorescence intensity of 
particles in vivo. 
 
 
Figure 9. Ex vivo images of different organs collected from the mice (I) without (negative 
control) and (II) after intravenous injection with 22 nm rhodamine-labelled PS latex particles. 
Organs dissected from the mice were visualised by (a) X-ray, (b) fluorescence and (c) X-
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ray/fluorescence overlay modes. An eppendorf tube containing the 22 nm rhodamine-tagged 
latex particles before in vivo injection was used for comparing with the fluorescence intensity 
of the organs: (1-2) Heart, (3-4) lungs, (5-6) liver, (7-8) kidneys.  
 
Conclusions 
Poly(acrylamide) stabilized nanoparticles were produced by surfactant free RAFT emulsion 
polymerisation. The size of the colloids was controlled by the ratio of monomer to macro-
CTA in emulsion, resulting in nanoparticles with 11 and 22 nm diameter respectively. Free 
carboxylic acid functional groups on the stabilizer chains were used for fluorescence labelling 
with rhodamine B. For this purpose, the commercially available isothiocyanate functionalized 
dye was hydrolysed in an aqueous environment to yield rhodamine B with primary amine 
functions. Attachment was utilized using EDC/NHS coupling and resulted in the 
functionalization of 10% and 12% of the available functional groups for the 11 and 22 nm 
particles, respectively. This corresponded to 10 and 14 dye molecules per particle.  
The rhodamine-labelled PS latex particles were used to monitor the cellular uptake and 
biodistribution in vitro and in vivo. Both 11 nm and 22 nm fluorescent particles were taken up 
by HK2 cells and localised in the cytoplasm after 24 hours of incubation. The cytoplasm can 
be the target site for the nanoparticles for potential applications in the intracellular delivery of 
miRNA, which could only be processed into RISC in the cytoplasm for mRNA targeting.  
For in vivo studies, the 22 nm rhodamine-tagged particles were intravenously injected into a 
mouse model systemically and were found to transport through the vasculature of the mouse 
torso and limbs. Ex vivo studies revealed that the fluorescent particles were distributed 
predominantly in the mouse liver, followed by the lungs, kidneys and the heart. Pulmonary 
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retention of the particles could possibly be due to slow transportation by the small capillaries 
present in the alveolar vasculature.  
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Experimental 
Materials for the synthesis of rhodamine-labelled PS latex particles. PAAm stabilised PS latex 
particles (11 nm and 22 nm) were synthesised according to protocol described in Supporting 
Information. Rhodamine B isothiocyanate (RBITC, mixed isomers, Sigma-Aldrich), N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 98+%, purum, Sigma-
Aldrich), N-hydroxysuccinimide (NHS, 99.8%, Sigma-Aldrich), methanol for ESI-MS 
(MeOH, 99.80%, HPLC grade, Merck), were used as received. Water was purified by Milli-
Q® Integral Water Purification System (resistivity of water = 18.2 MΩ · cm at 25°C). 2-(N-
Morpholino)ethanesulfonic acid (MES, 99+%, Sigma-Aldrich) buffer stock solution (100 
mM, pH 5.65) was prepared with Milli-Q water and the pH was adjusted with aqueous NaOH 
(100 mM).  
Electrospray ionisation mass spectrometry (ESI-MS). Rhodamine dyes were characterised on 
mass spectrometer (Finnigan™ LCQ™ Deca), using MeOH (HPLC grade) as the eluent at a 
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flow rate of 0.2-0.4 mL/min and nitrogen as the sheath gas, with the electrospray voltage set 
at 4.5 kV and capillary temperature at 300 °C. Samples were diluted to a final concentration 
of ~ 0.1 mg/mL and filtered through 0.20 µm membrane before injection.  
Ultraviolet-visible (UV-Vis) spectrometry. UV-Vis absorbance of the rhodamine-labelled PS 
latex particles and free rhodamine B amine were measured using UV-Vis-NIR spectrometer 
(Varian Cary 5000, Agilent). Measurements were taken in the range of 260-800 nm at 600 
nm/min.  
Preparation of UV-Vis calibration curve of rhodamine B amine. Aqueous rhodamine B amine 
solution prepared was diluted with water to different concentrations in the range of 3-37 µM. 
The absorbance values of the rhodamine B amine solutions at 552 nm were collected for the 
construction of standard curve. Water was used as the blank for the measurement. 
Fluorescence spectroscopy. Fluorescence of free and conjugated rhodamine was detected by 
fluorescence spectrometer (Cary Eclipse, Agilent). Samples were scanned at 600 nm/min, 
with the excitation and emission slits set at 10 nm width. 
Preparation of rhodamine B amine from hydrolysis of rhodamine B isothiocyanate (RBITC). 
RBITC (0.0050g, 0.0097 mmol) was dissolved in water (25 g) and stirred at room temperature 
overnight. ESI-MS (m/z): amine derivative of rhodamine B [C28H32N3O3]+ = 458; unreacted 
isothiocyanate derivative of rhodamine B [C29H30N3O3]+ = 500.  
Typical synthesis of rhodamine-labelled polymeric nanoparticles. 11 nm PS latex (SC = 
0.37%, 2.5 mL) was diluted in MES buffer (100 mM, pH 5.65, 2.5 mL), followed by mixing 
with EDC (0.0183 g, 0.096 mmol) and NHS (0.0227 g, 0.197 mmol) for an hour at room 
temperature. After the addition of aqueous rhodamine B amine solution (0.4 mM, 2.5 mL, 
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1.01 µmol), the reaction was kept in the dark and stirred overnight at room temperature 
(Scheme 1). The rhodamine-conjugated latex particles were purified by dialysis against Milli-
Q water (MW cut-off = 2000 g/mol) in the dark. SC of the particles after modification = 
0.12%. The absorbance and conjugation efficiency of the rhodamine-functionalised particles 
was checked by UV-Vis spectrometry, using water as the blank for the measurements. 
Rhodamine fluorescence from the particles was detected by fluorescence spectroscopy. 
Cell culture. The cellular uptake of rhodamine-labelled PS latex particles was studied in 
healthy human renal proximal tubular cell line (HK2, provided by the Renal Research 
Laboratory, Kolling Institute of Medical Research, the Royal North Shore Hospital). 
Confluent monolayers of HK2 cells were grown in keratinocyte-serum-free medium (Gibco), 
which was supplemented with 50 µg/mL bovine pituitary extract (Gibco) and 5 ng/mL 
recombinant human epidermal growth factor (Gibco). The cells were cultured under 
humidified conditions at 37 °C with 5% (v/v) CO2. For sub-culturing, the growth media was 
removed from the cells, which were then rinsed with phosphate buffer saline (PBS, In vitro 
Technologies). After the addition of 0.25% (w/v) trypsin (SAFC Biosciences), the cells were 
detached from the surface and washed with fresh culture medium. The rinsed cells were 
collected by centrifugation at 1000 g for 3 minutes and transferred to fresh culture medium for 
incubation. 
Cellular uptake of rhodamine-tagged PS latex particles. Rhodamine-labelled latex particles 
were sterilised by filtering through a 0.22 µm filter. The sterilised particles were diluted with 
cell culture media to a final concentration of 10 ppm for incubation with HK2 cells for 24 
hours. Localisation of the rhodamine-tagged particles in HK2 cells was imaged under 
confocal microscopy. The nuclei of the HK2 cells were visualised under confocal microscopy 
by fluorescent staining: HK2 cells dosed with 22 nm rhodamine-tagged particles were 
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immobilised on glass surface and stained with 4',6-diamidino-2-phenylindole (DAPI, Life 
Technologies) in mounting media for confocal microscopy overnight before imaging; HK2 
cells incubated with 11 nm rhodamine-labelled particles were stained with Hoechst 30 
minutes prior to imaging. 
Cellular uptake studies of 22 nm rhodamine-tagged PS latex particles. The uptake of the 22 
nm rhodamine-labelled particles by HK2 cells was observed under a confocal microscope 
(TCS SP5, Leica Microsystems). Images were taken with an.63× oil objective, with the 
numerical aperture set at 1.4. Fluorescence of (DAPI) in the nuclei of HK2 cells was captured 
between 415 nm and 556 nm by excitation at 405 nm. Rhodamine fluorescence signal in HK2 
cells was imaged between 614 nm and 748 nm by excitation at 561 nm. 
Cellular uptake studies of 11 nm rhodamine-tagged PS latex particles. The localisation of the 
11 nm rhodamine-tagged PS latex particles in HK2 cells was imaged under an inverted 
confocal microscope (Olympus FV1000). The imaging was performed with a 60× water 
objective, with the numerical aperture set at 1.2. Fluorescence of Hoechst stain in the nuclei 
of HK2 cells was collected between 425 nm and 475 nm by excitation at 405 nm. Cellular 
rhodamine fluorescence was captured between 570 nm and 670 nm by excitation at 559 nm. 
Animal model for rhodamine-labelled PS latex particle injection. Animal experiments were 
approved by the Royal North Shore Hospital Animal Care and Ethics Committee, Australia 
(Protocol No. 1310-001A). Injection of rhodamine-tagged PS latex particles were performed 
in 8-week-old healthy male mice (C57BL/6, Kolling Institute of Medical Research, the Royal 
North Shore Hospital), each weighing around 25 g. 
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In vivo and ex vivo imaging. In vivo and ex vivo imaging were performed on a preclinical 
animal imaging system (In-vivo FX PRO, Burker). X-ray and fluorescence detection modes 
were used for visualising the mouse skeletal features and biodistribution of the rhodamine-
tagged particles, respectively. Fluorescence of rhodamine signals was collected at 600 nm by 
excitation at 550 nm. Fluorescence images were obtained by subtracting the skin auto-
fluorescence of the animal models with spectral unmixing, using fluorescence of rhodamine-
labelled particles as the control. 
In vivo and ex vivo studies of 22 nm rhodamine-tagged PS latex particles. The mice were 
given an inhalational anaesthetic (2% (v/v) isoflurane) prior to nanoparticle administration. 
200 µL of rhodamine-labelled latex dispersed in PBS buffer (12.3 ppm) was injected into the 
lateral veins of the mouse tails. The biodistribution of the fluorescent particles in vivo was 
visualised by a preclinical animal imaging system. Forty minutes after particle injection, the 
mice were anaesthetised with 2% (v/v) isoflurane and underwent pericardiectomy. The mice 
were perfused with PBS before organ removal. The fluorescence images of the mouse heart, 
lungs, liver and kidneys ex vivo were collected by preclinical animal imaging system. A 
healthy mouse without particle injection was also sacrificed for pericardiectomy to serve as 
the negative control for the ex vivo studies. 
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